dihexa hgf/c-met agonist cancer risk hgf c-met c met Targeting the pathway in advanced pancreatic cancer dihexa cancer risk hgf c-met – dihexa hgf/c-met agonist A novel
Pay in 4 interest-free payments of $6.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17











![A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1]](https://www.preprints.org/frontend/picture/ms_xml/manuscript/28233dba55c7b404c1a8e0b10dd5de8e/preprints-107031-g002.png)

69705-5/asset/c1849453-db0f-44a3-bbc5-cee52696908c/main.assets/gr1.jpg)















